Table 2

Baseline echocardiographic parameters

VariablePopulation (n=2011)SMR without SAD (n=592)SADMR (n=1419)P value
LV end-diastolic volume, mL182.9±73.5160.4±60.9191.5±76.1<0.001
LV end-systolic volume, mL124.3±59.6108.2±48.2130.4±62.3<0.001
LV EF, %33.2±9.233.5±9.333.1±9.10.34
MV mean gradient, mm Hg3.78±1.53.97±1.53.77±1.50.31
MV peak gradient, mm Hg10.4±3.812±8.111.6±90.72
MR Vmax, m/sec4.9±0.84.9±0.84.9±0.80.59
EROA, mm241.7±26.141.2±29.441.9±24.70.63
Mitral annulus calcification600 (30%)164 (28%)436 (31%)0.16
SPAP, mm Hg50.8±15.149±1552±150.001
Moderate or severe RV dilation, %733 (36)170 (29)563 (40)<0.001
Moderate or severe RV dysfunction, %672 (33)181 (31)491 (35)0.09
Moderate or severe tricuspid regurgitation, %1200 (60)300 (51)900 (63)<0.001
Diastology measurements
 Deceleration time, msec166.7±52.2170.2±51.6165.1±52.40.13
 Peak A velocity, cm/sec0.61±0.30.72±0.30.61±0.35<0.001
 Peak E velocity, cm/sec1.2±0.31.2±0.31.2±0.30.24
 E/A8.9±6.13.2±13.911.8±2.90.08
 E/e’ average ratio20.6±8.520.9±7.920.5±8.70.54
  • Significant p-values (<0.05) are highlighted in bold.

  • EF, ejection fraction; EROA, effective regurgitant orifice area; LV, left ventricle; MR, mitral regurgitation; MV, mitral valve; RV, right ventricle; SAD, severe atrial dilation mitral; SMR, secondary mitral regurgitation; SPAP, systolic pulmonary arterial pressure; Vmax, maximum velocity.